GH – guardant health, inc. (US:NASDAQ)

News

Roche builds MRD testing arsenal in $595m Saga Diagnostics buyout [Yahoo! Finance]
Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026
Guardant Health (GH) had its "overweight" rating reaffirmed by Barclays PLC.
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know [Yahoo! Finance]
Guardant Health: Leveraging Liquid Biopsy Testing Momentum [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com